-
, CRISPR-based approaches, transfection/transduction, and in vitro bacterial infection models. Apply omics approaches (e.g., epigenomics, transcriptomics, proteomics) to support drug targetidentification and
-
and organoid platforms, genome engineering technologies, advanced microscopy, spectral flow cytometry, single-cell and spatial genomics, proteomics and biomarker laboratories, and high-performance
-
multidisciplinary team integrating molecular biology, genomics, epigenomics, microbiome science, proteomics, and clinical research. The position will focus on the development and evaluation of low-input whole genome
-
biology, genomics, epigenomics, microbiome science, proteomics, and clinical research. The position will focus on the development and evaluation of low-input whole genome sequencing and study of genotoxic
-
, metabolomics, proteomics) is an asset. Knowledge of data harmonization platforms (e.g., Maelstrom Research guidelines) is an asset. Experience with high-performance computing environments (Unix/HPC clusters) is
-
at the molecular and tissue level, and how its disruption contributes to hereditary cancers and pediatric malignancies (https://bcchr.ca/maxwell-lab ). Key areas include: Mechanisms of cell division fidelity
-
Research Institute and UBC, investigates how cell division is regulated at the molecular and tissue level, and how its disruption contributes to hereditary cancers and pediatric malignancies (https
-
regulated at the molecular and tissue level, and how its disruption contributes to hereditary cancers and pediatric malignancies (https://bcchr.ca/maxwell-lab ). Key areas include: Mechanisms of cell